Fundz

hephaistos.bio secures €161K to advance sustainable chemical manufacturing, focusing on custom enzyme solutions for the pharmaceutical sector.

PRIVATEJun 01, 2026

Amount Raised

€161,000

Round Type

Pre-Seed

SwitzerlandManufacturingBiotechnology

Investors

Venture Kick

Description

Swiss biotech startup hephaistos.bio has secured €161,000 (CHF 150,000) from Venture Kick to accelerate the development of custom enzyme solutions for pharmaceutical and chemical manufacturing. The startup aims to support companies in reshoring production to Europe through sustainable manufacturing processes. Their end-to-end enzyme design platform targets chemical reactions that traditional solutions struggle with. This investment will help enhance sustainability, resilience, and cost efficiency in manufacturing.

Quick answer

hephaistos.bio raised €161,000 in a Pre-Seed round, dated June 1, 2026. Investors: Venture Kick. hephaistos.bio is based in Switzerland.

How much did hephaistos.bio raise?
hephaistos.bio raised €161,000 in a Pre-Seed round on June 1, 2026.
Who invested in hephaistos.bio?
Venture Kick is named as investors in this round.
What does hephaistos.bio do?
hephaistos.bio is a Swiss biotech startup focused on developing custom enzyme solutions for sustainable chemical manufacturing.
Where is hephaistos.bio based and how big is it?
hephaistos.bio is based in Switzerland. Fundz records about 6 employees.
Who are the decision-makers at hephaistos.bio?
Fundz holds 2 contacts at hephaistos.bio, including the Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at hephaistos.bio, and when

A new round usually means hephaistos.bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day hephaistos.bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at hephaistos.bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at hephaistos.bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

hephaistos.bio

Location

Switzerland

About

hephaistos.bio is a Swiss biotech startup focused on developing custom enzyme solutions for sustainable chemical manufacturing. The company leverages expertise in computational biology, machine learning, and structural biology to design biocatalysts for industrial applications. By enabling more efficient production processes, hephaistos.bio aims to reduce the environmental impact associated with traditional chemical manufacturing. Their technology is currently being tested in collaboration with industry partners to enhance the competitiveness of European manufacturing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment hephaistos.bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJannik N., Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for hephaistos.bio's next move

See what Strategic adds

hephaistos.bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.